Cargando…
Rapid evaluation of the safety of COVID-19 vaccines: how well have we done?
Autor principal: | Miller, Elizabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733286/ https://www.ncbi.nlm.nih.gov/pubmed/34999173 http://dx.doi.org/10.1016/j.cmi.2021.12.018 |
Ejemplares similares
-
Australia's public health response to COVID‐19: what have we done, and where to from here?
por: Johnston, Ingrid
Publicado: (2020) -
COVID-19: What we’ve done well and what we could or should have done better—the 4 Ps
por: Vincent, Jean-Louis, et al.
Publicado: (2021) -
Reply: Have we done the best that we could have done?
por: Arora, Rakesh C., et al.
Publicado: (2020) -
COVID-19 in Iran: What was done and what should be done
por: Nojomi, Marzieh, et al.
Publicado: (2021) -
Time-restricted feeding: what we have done and what more we can do?
por: Sun, Yuning, et al.
Publicado: (2023)